ASIM KUMAR (Ph.D.)

About

Dr. Asim Kumar obtained Bachelor of Pharmacy from SHUATS, Allahabad; (A U. P. State University) in 2011. He qualified national level GPAT (Graduate Pharmacy Aptitude Test)-2011 examination with all India rank (AIR) of 89 and NIPER JEE-2011 with AIR of 08. He earned M.S. (Pharm.) in Medicinal Chemistry from NIPER Mohali (2013). He received Ph.D. (2018) under the supervision of Prof. Asit K. Chakraborti from NIPER Mohali. GATE-2013 (Graduate Aptitude Test in Engineering-Chemical Sciences) with 95 percentile and NIPER JAT-2013 with AIR of 02 allowed his transition into JRF/SRF. He has published 30 top-rated academic research/ review journals including ACS Catalysis (IF 13.06), European Journal of Medicinal Chemistry (IF 6.8) and Catalysis Science and Technology (IF 5.36). He has also co-authored a book chapter titled as “Green Chemistry: Synthesis of Bioactive Heterocycles” for Springer publishers. Dr. Kumar's research interests include development of new methodologies for the synthesis of bioactive heterocycles via green synthetic protocols//Organocatalytic transformations/C-H bond activation/cross coupling reactions and development of methodologies for heterobimetallic nanoparticles catalyzed organic transformations. Currently he is working as Assistant Professor in Amity University Haryana, India since 2018.

Employment

• Amity University Haryana Assistant Professor
  2018 - Present

Education

• National Institute of Pharmaceutical Education and Research Ph.D.
  2013 - 2018
• National Institute of Pharmaceutical Education and Research M.S. (Pharm.)
  2011 - 2013
• Sam Higginbottom Institute of Agriculture Technology and Sciences Faculty of Health Sciences B.Pharm
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (36)

• Contemporary trends in targeted protein degradation for neurodegenerative diseases
  European Journal of Medicinal Chemistry 2025 DOI: 10.1016/j.ejmech.2025.118110
  +Save
• Docking and Simulation Studies on Novel Analogues of 3,4,5-Trihydroxy Benzoic Acid as HSP90Alpha Inhibitors
  Letters in Organic Chemistry 2025 DOI: 10.2174/0115701786312992240702100154
  +Save
• Drugs and Their Mode of Action: A Review on Sulfur-Containing Heterocyclic Compounds
  Polycyclic Aromatic Compounds 2025 DOI: 10.1080/10406638.2024.2392781
  +Save
• Favipiravir: A Promising Nucleotide Analog for Treatment of COVID-19
  Springer Transactions in Civil and Environmental Engineering 2025 DOI: 10.1007/978-981-96-4047-8_4
  +Save
• Recent Advances in the Development of Greener Methodologies for the Synthesis of Benzothiazoles
  Current Topics in Medicinal Chemistry 2025 DOI: 10.2174/0115680266347975241217112119
  +Save
• Recent Expansions in Anti-Microbial Profile of Quinoline Analogues: A Review
  Current Organic Chemistry 2025 DOI: 10.2174/0113852728367743250520191343
  +Save
• Contemporary trends on the kinase inhibitors with special reference to quinoxaline derivatives
  Molecular Diversity 2025 DOI: 10.1007/s11030-025-11423-z
  +Save
• Water as benign reaction medium for the synthesis of quinoxaline
  2024
  +Save
• Phosphorus Heterocycles and Their Biological Applications
  Chemistryselect 2024 DOI: 10.1002/slct.202404258
  +Save
• Motor and non-motor symptoms, drugs, and their mode of action in Parkinson’s disease (PD): a review
  Medicinal Chemistry Research 2024 DOI: 10.1007/s00044-024-03203-5
  +Save